Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells
/in International Publications, Malignant Melanoma /von 2006-12-19 / Biotechnol. Lett. 2007 Mar;29(3):351-7Steady-state and inflammatory dendritic-cell development
/in Dendritic Cells, International Publications /von 2006-12-15 / Nat. Rev. Immunol. 2007 Jan;7(1):19-30Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells
/in Dendritic Cells, Hyperthermia, International Publications /von 2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-58Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism
/in Hyperthermia, International Publications /von 2006-12-01 / Nat. Immunol. 2006 Dec;7(12):1299-308[Dendritic cells and gliomas: a hope in immunotherapy?]
/in Glioblastoma, International Publications /von 2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-70Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells
/in Colorectal Cancer, International Publications /von 2006-12-01 / Oncol. Rep. 2006 Dec;16(6):1317-24Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ
/in Colorectal Cancer, International Publications /von 2006-12-01 / Ann. Surg. 2006 Dec;244(6):986-92; discussion 992-3Artificial cytokine storm combined with hyperthermia induces significant anti-tumor effect in mice inoculated with lewis lung carcinoma and B16 melanoma cells
/in International Publications, NSCLC /von 2006-12-01 / Int J Hyperthermia 2006 Dec;22(8):699-712Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy
/in Acute Leukemia, International Publications /von 2006-12-01 / J Clin Apher 2006 Dec;21(4):233-40
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution